IDEXX Laboratories, Inc. vs Invesco WilderHill Clean Energy ETF — how do they compare? IDEXX Laboratories, Inc. trades at $572.98 (market cap $46.22B), while Invesco WilderHill Clean Energy ETF trades at $34.83. The key difference: Invesco WilderHill Clean Energy ETF is trading nearer its 52-week high, IDEXX Laboratories, Inc. nearer its low. Which is the better fit depends on your goals.
| IDXX | PBW | |
|---|---|---|
Market Cap | $46.22B | — |
Sector | Health | Sector/Thematic |
52-Week High | $766.68 | $46.99 |
52-Week Low | $526.44 | $24.14 |
Enterprise Value | $47.12B | — |
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $595.76, up 1.55% on the day, with a bullish technical signal and strong fundamental performance. Recent Q2 2026 earnings beat expectations with EPS of $4.27 versus $3.94 expected, driven by 9% organic revenue growth. The company raised full-year EPS guidance to $14.69–14.94, reflecting robust demand in companion animal diagnostics. Valuation ratios remain elevated with a P/E of 41.23, supported by high profitability margins including a net income margin of 25.03% and ROE of 74.21%.
Outlook is positive given consistent earnings beats, international expansion, and product innovation, but risks include premium valuation sensitivity and competitive pressures. The consensus price target of $683.33 implies 14.7% upside, with 57% of analysts rating it Buy. Investors should weigh growth durability against high multiples.
PBW trades at $34.93, up 0.92% today, with a bullish technical signal from moving averages but neutral oscillators. The ETF benefits from clean energy tailwinds, including rising global investment and energy security concerns, yet lacks disclosed fundamental ratios. Recent news highlights volatility linked to interest rate movements and sector rotations.
Outlook is mixed: clean energy demand offers growth potential, but sensitivity to Treasury yields and tech sell-offs poses risks. Investors face upside from policy support offset by macroeconomic headwinds and valuation uncertainties due to missing financial data.
Trailing returns across standard periods
Latest headlines on both assets
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →PBW is an equal-weighted ETF that invests in U.S. companies leading the clean energy transition. It focuses on renewable energy, power conservation, and sustainable technologies like solar, wind, and energy storage.
Read more on PBW →